Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mieleckiego Slaskiego Uniwersytetu Medycznego W Katowicach — Clinical Trial Site

17 Registered trials

10 Currently recruiting

Organisation

Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mieleckiego Slaskiego Uniwersytetu Medycznego W Katowicach

Location

Katowice, Poland

Identifier

ORG-100030678

Address

Ul. Henryka Dabrowskiego 25, 40-032, Poland

Departments

Katedra i Klinika Nefrologii, Transplantologii i Chorób Wewnętrznych
Klinika Hematologii i Transplantacji Szpiku
Nefrologii, Transplantologii i Chorób Wewnętrznych
Oddzial Hematologii i Transplantacji Szpiku
Oddział Hematologii i Transplantacji Szpiku
Oddział Hematologii i Transplantacji Szpiku Ul. Dąbrowskiego 25, 40-032 Katowice
Oddział Hematologii i Transplantologii Szpiku
Oddział Nefrologii, Transplantologii i Chorób Wewnętrznych
Odział Hematologii I Transplantacji Szpiku
Poradnia Leczenia Nadciśnienia Tętniczego

Clinical trials at this site (17)

Search interface

A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/… Pending

2024-518275-64-00 Diffuse large B-cell lymphomas (DLBCL, Diffuse large B- 4
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residua… Recruiting

2024-512503-39-00 Arm A (AML): Newly diagnosed de novo Acute myeloid leuk 6 2025-12-19
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A Recruiting

2025-520490-38-00 Haemophilia A with or without inhibitors. Proposed indi 3 2025-10-13
A phase III placebo-controlled efficacy and safety study of mocravimod as an adjunctive and maintenance treatment in AML patients undergoing… Recruiting

2024-512752-38-00 Adjunctive and maintenance treatment to HCT 5 2025-09-09
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Mainten… Recruiting

2023-509755-13-00 Idiopathic steroid-sensitive nephrotic syndrome 5 2025-04-28
MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leu… Recruiting

2023-503394-37-00 Acute Myeloid Leucaemia 5 2024-10-23
Allopurinol as a preventive drug in patients with high and very high cardiovascular risk, taking into account the presence of the long-COVID… Recruiting

2024-517610-15-00 hyperuricemia, hypertension, ischemic stroke, intracere 5 2024-03-28
Optimal medical treatment of difficult-to-treat hypertension. Recruiting

2024-517628-20-00 hypertension 11 2023-10-24
SACK Recruiting

2022-501600-10-00 Atrial fibrillation and Chronic Kidney Disease stage 5 5 2023-02-07
MLS-101-901: An Open-Label Extension Study to Assess the Long-Term Safety, Efficacy, and Tolerability of Lorundrostat in Subjects with Hyper… Ended

2023-508670-28-00 Hypertension 5 2024-08-26
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplas… Ended

2023-509947-29-00 Anemia in patients with very low, low or intermediate r 4 2024-07-18
PACIFICA: A Phase 3 Study of Pacritinib in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thro… Ended

2024-515953-52-00 Post-Essential Thrombocythaemia Myelofibrosis 5 2020-07-24
MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of … Ended

2023-506425-12-00 Uncontrolled and Resistant Hypertension 5 2024-04-17
Efficacy and safety of obinutuzumab versus rituximab in combination with chemotherapy for adult patients with newly diagnosed CD20-positive … Ended

2024-517389-40-00 acute lymphoblastic leukemia 4 2021-10-06
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea… Ended

2024-511235-10-00 Generalized mantle cell Lymphoma 5 2016-07-25